Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
That is all the official record says: Immunomic Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
No investor of Immunomic Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 8 rounds above had up to 60 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
People named by Immunomic Therapeutics, Inc.
Name
Role
Named in
Dong-Gun Kim
Executive officer
Jun 2025
C. Eric Winzer
Executive officer
Apr 2024
William G. Hearl
Chief Executive Officer and Director
Jan 2021
Bernard C Rudnick
Chief Financial Officer and Director
Oct 2014
Bernard C. Rudnick
Chief Financial Officer and Director
Oct 2014
Bruce F. Mackler
Vice President for Regulatory Affairs and Director
Oct 2014
James D. Wishart
Secretary and Director
Oct 2014
Teri Jones Heiland
Vice President--Research and Development
Oct 2014
William G Hearl
Chief Executive Officer, Director and Founder
Oct 2014
Bruce C Mackler
Vice President and Director
Jun 2013
Lisa C Salley
Chief Operating Officer
Jun 2013
Winston I Lowe
General Counsel and Secretary of the Board of Directors
Jun 2013
Teri Barry Heiland
Vice President of Research and Development
Mar 2012
Dong-Gun Kim
Director
Jun 2025
James Wishart
Director
Jun 2025
Ki-Hong Ahn
Director
Jun 2025
Matthew Chang
Director
Jun 2025
Robert Ahlgren
Director
Jun 2025
Steve Park
Director
Jun 2025
Yang Gon Jin
Director
Jun 2025
James ERIC Wishart
Director
Apr 2024
Ki-Hong ERIC Ahn
Director
Apr 2024
Matthew ERIC Chang
Director
Apr 2024
Michael ERIC Lack
Director
Apr 2024
Robert ERIC Ahlgren
Director
Apr 2024
Ronald ERIC Thiboutot
Director
Apr 2024
Steve ERIC Park
Director
Apr 2024
Yang Gon ERIC Jin
Director
Apr 2024
Alex S Kim
Director
Jan 2021
Arlo P. Mcginn
Director
Jan 2021
C. Eric Winzer
Chief Financial Officer and Director
Jan 2021
Hyuk Joo P. Jee
Director
Jan 2021
James W. Wishart
Director
Jan 2021
Michael D. Lack
Director
Jan 2021
Ronald P. Thiboutot
Director
Jan 2021
William G. Hearl
Chief Executive Officer and Director
Jan 2021
Yang-Gon P. Jin
Director
Jan 2021
Bernard C Rudnick
Chief Financial Officer and Director
Oct 2014
Bernard C. Rudnick
Chief Financial Officer and Director
Oct 2014
Bruce F. Mackler
Vice President for Regulatory Affairs and Director